Hobbs F D, Holmes J, Pugner K
Department of General Practice, University of Birmingham, London.
Br J Gen Pract. 1998 Feb;48(427):983-4.
This study explored general practitioner (GP) perceptions of use of treatments to manage hyperlipidaemia and their cost implications. GPs recognized different levels of coronary heart disease (CHD) risk, but were not always aware of which were major factors. Most were unfamiliar with published guidelines on managing hyperlipidaemia, and were likely to initiate drug therapies even in low-risk patients with mild hyperlipidaemia. Clearer advice is needed on whom to treat and on dietary intervention with high-fibre as well as low-fat diets.
本研究探讨了全科医生（GP）对使用治疗方法管理高脂血症及其成本影响的看法。全科医生认识到冠心病（CHD）存在不同程度的风险，但并不总是清楚哪些是主要因素。大多数人不熟悉已发表的高脂血症管理指南，甚至可能对轻度高脂血症的低风险患者启动药物治疗。在治疗对象以及高纤维和低脂饮食的饮食干预方面，需要更明确的建议。
